Citation: D. Landman et al., FAILURE OF ALL ANTIFUNGAL THERAPY FOR INFECTION DUE TO CANDIDA-ALBICANS - A NEW AIDS-RELATED PROBLEM, Clinical infectious diseases, 26(1), 1998, pp. 183-184
Authors:
QUALE JM
LANDMAN D
WALLACE B
ATWOOD E
DITORE V
FRUCHTER G
Citation: Jm. Quale et al., DEJA-VU - NOSOCOMIAL HEPATITIS-B VIRUS TRANSMISSION AND FINGERSTICK MONITORING, The American journal of medicine, 105(4), 1998, pp. 296-301
Citation: G. Saurina et al., ACTIVITY OF DISINFECTANTS AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM, Infection control and hospital epidemiology, 18(5), 1997, pp. 345-347
Citation: D. Landman et Jm. Quale, MANAGEMENT OF INFECTIONS DUE TO RESISTANT ENTEROCOCCI - A REVIEW OF THERAPEUTIC OPTIONS, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 161-170
Citation: Mm. Zaman et al., RAPID DEVELOPMENT OF RENAL-INSUFFICIENCY WITH THE SIMULTANEOUS ADMINISTRATION OF AMPHOTERICIN-B AND FOSCARNET, Clinical infectious diseases, 22(2), 1996, pp. 378-378
Authors:
LANDMAN D
QUALE JM
BURNEY S
KREISWIRTH B
WILLEY BM
Citation: D. Landman et al., TREATMENT OF EXPERIMENTAL ENDOCARDITIS CAUSED BY MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH RAMOPLANIN AND PENICILLIN, Journal of antimicrobial chemotherapy, 37(2), 1996, pp. 323-329
Citation: Mm. Zaman et al., TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH CLINAFLOXACIN AND PENICILLIN, Journal of antimicrobial chemotherapy, 37(1), 1996, pp. 127-132
Authors:
QUALE JM
LANDMAN D
ZAMAN MM
BURNEY S
SATHE SS
Citation: Jm. Quale et al., IN-VITRO ACTIVITY OF CINNAMOMUM-ZEYLANICUM AGAINST AZOLE RESISTANT AND SENSITIVE CANDIDA SPECIES AND A PILOT-STUDY OF CINNAMON FOR ORAL CANDIDIASIS, The American journal of Chinese medicine, 24(2), 1996, pp. 103-109
Authors:
LANDMAN D
QUALE JM
OYDNA E
WILLEY B
DITORE V
ZAMAN M
PATEL K
SAURINA G
HUANG W
Citation: D. Landman et al., COMPARISON OF 5 SELECTIVE MEDIA FOR IDENTIFYING FECAL CARRIAGE OF VANCOMYCIN-RESISTANT ENTEROCOCCI, Journal of clinical microbiology, 34(3), 1996, pp. 751-752
Citation: D. Landman et al., AMPICILLIN PLUS CIPROFLOXACIN THERAPY OF EXPERIMENTAL ENDOCARDITIS CAUSED BY MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM, Journal of antimicrobial chemotherapy, 36(1), 1995, pp. 253-258
Citation: Fr. Dimaio et al., IN-VITRO ELUTION OF CIPROFLOXACIN FROM POLYMETHYLMETHACRYLATE CEMENT BEADS, Journal of orthopaedic research, 12(1), 1994, pp. 79-82
Citation: Jm. Quale et al., TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH CIPROFLOXACIN AND NOVOBIOCIN, Journal of antimicrobial chemotherapy, 34(5), 1994, pp. 797-802
Citation: N. Mobarakai et al., IN-VITRO ACTIVITY OF TROSPECTOMYCIN, A NEW AMINOCYCLITOL ANTIBIOTIC, AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM, Journal of antimicrobial chemotherapy, 33(2), 1994, pp. 319-321
Citation: S. Burney et al., ACTIVITY OF CLINAFLOXACIN AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1668-1670
Citation: N. Mobarakai et al., BACTERICIDAL ACTIVITIES OF PEPTIDE ANTIBIOTICS AGAINST MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 385-387
Citation: D. Landman et al., NOVEL ANTIBIOTIC REGIMENS AGAINST ENTEROCOCCUS-FAECIUM RESISTANT TO AMPICILLIN, VANCOMYCIN, AND GENTAMICIN, Antimicrobial agents and chemotherapy, 37(9), 1993, pp. 1904-1908